Literature DB >> 18031001

Novel di- and tetracarboxylatoplatinum(IV) complexes. Synthesis, characterization, cytotoxic activity, and DNA platination.

Michael R Reithofer1, Seied M Valiahdi, Michael A Jakupec, Vladimir B Arion, Alexander Egger, Mathea Sophia Galanski, Bernhard K Keppler.   

Abstract

Octahedrally configured diaminedichloro- and diamineoxalatoplatinum(IV) complexes with axial hydroxo ligands were carboxylated with succinic or glutaric anhydride. The free, uncoordinated carboxylic acid groups were further derivatized with amines and alcohols to the respective amides and esters and characterized in detail by elemental analysis, mass spectrometry, and multinuclear (1H, 13C, 15N, and 195Pt) NMR spectroscopy. Cytotoxicity of the complexes was studied in four human cancer cell lines derived from ovarian carcinoma (CH1, SK-OV-3), cervical carcinoma (HeLa), and colon carcinoma (SW480) by means of the MTT assay. Structure-activity relationships revealed a low activity for platinum complexes with underivatized carboxylic acid moieties and amide derivatives displaying the hydroxyethylamino residue. Within the series of amides, cyclopentylamino analogues were equipped with the highest cytotoxic potential. However, ester derivatives yielded IC50 values mostly in the low micromolar range and comparable to those of cisplatin. DNA platination studies of selected complexes revealed a high DNA platination capacity in parallel to a high cytotoxic potential and vice versa.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18031001     DOI: 10.1021/jm070897b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  19 in total

1.  Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes.

Authors:  James A Platts; Giuseppe Ermondi; Giulia Caron; Mauro Ravera; Elisabetta Gabano; Luca Gaviglio; Giorgio Pelosi; Domenico Osella
Journal:  J Biol Inorg Chem       Date:  2010-11-16       Impact factor: 3.358

Review 2.  Synthetic methods for the preparation of platinum anticancer complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Chem Rev       Date:  2013-11-27       Impact factor: 60.622

3.  Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Inorg Chem       Date:  2011-03-01       Impact factor: 5.165

4.  Diamminetetrakis(carboxylato)platinum(IV) complexes--synthesis, characterization, and cytotoxicity.

Authors:  Björn R Hoffmeister; Mahsa S Adib-Razavi; Michael A Jakupec; Markus Galanski; Bernhard K Keppler
Journal:  Chem Biodivers       Date:  2012-09       Impact factor: 2.408

5.  Conjugation of cisplatin analogues and cyclooxygenase inhibitors to overcome cisplatin resistance.

Authors:  Wilma Neumann; Brenda C Crews; Menyhárt B Sárosi; Cristina M Daniel; Kebreab Ghebreselasie; Matthias S Scholz; Lawrence J Marnett; Evamarie Hey-Hawkins
Journal:  ChemMedChem       Date:  2014-10-15       Impact factor: 3.466

6.  Oxidative Reactivity and Cytotoxic Properties of a Platinum(II) Complex Prepared by Outer-Sphere Amide Bond Coupling.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Polyhedron       Date:  2013-07-13       Impact factor: 3.052

7.  Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells.

Authors:  Nora Graf; Tara E Mokhtari; Ioannis A Papayannopoulos; Stephen J Lippard
Journal:  J Inorg Biochem       Date:  2012-02-23       Impact factor: 4.155

8.  Conjugates of cisplatin and cyclooxygenase inhibitors as potent antitumor agents overcoming cisplatin resistance.

Authors:  Wilma Neumann; Brenda C Crews; Lawrence J Marnett; Evamarie Hey-Hawkins
Journal:  ChemMedChem       Date:  2014-05-06       Impact factor: 3.466

9.  Maleimide-functionalised platinum(IV) complexes as a synthetic platform for targeted drug delivery.

Authors:  Verena Pichler; Josef Mayr; Petra Heffeter; Orsolya Dömötör; Éva A Enyedy; Gerrit Hermann; Diana Groza; Gunda Köllensperger; Markus Galanksi; Walter Berger; Bernhard K Keppler; Christian R Kowol
Journal:  Chem Commun (Camb)       Date:  2013-03-18       Impact factor: 6.222

10.  Anticancer activity of methyl-substituted oxaliplatin analogs.

Authors:  Ute Jungwirth; Dimitris N Xanthos; Johannes Gojo; Anna K Bytzek; Wilfried Körner; Petra Heffeter; Sergey A Abramkin; Michael A Jakupec; Christian G Hartinger; Ursula Windberger; Markus Galanski; Bernhard K Keppler; Walter Berger
Journal:  Mol Pharmacol       Date:  2012-02-13       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.